オプションチェーンは、MEDIROM Healthcare Techsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、MEDIROM Healthcare Techsの市場センチメントを評価します。.

MEDIROM Healthcare Techs (NASDAQ:MRM) 株価情報, オプションチェーン

MEDIROM Healthcare Techs

MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.

MEDIROM Healthcare Technologies Inc. - American Depositary Share

MEDIROM Healthcare Technologies Inc

MMA Offshore Ltd

MariMed Inc

MIRAMAR RESOURCES LTD by MIRAMAR RESOURCES LTD

MRMAX HLDGS LTD by MRMAX HLDGS LTD

President Donald Trump's aggressive trade tariffs extend beyond Wall Street, rattling the Treasury market and the U.S. dollar. The turmoil is now challenging the long-held narrative of &#8220;American exceptionalism&#8221; that has underpinned global confidence in the <a href="https://www.benzinga.com/government/regulations/25/04/44710975/wall-streets-american-exceptionalism-trade-falters-as-dollar-stocks-bonds-all-slide">U.S. economy for decades.</a>
A broad trade-weighted measure of the dollar fell Friday to its lowest level since April 2022. The greenback is now down 10% since Trump's inauguration, raising concerns about its global reserve status.
Although recent March inflation reports showed cooling price pressures across both consumer and producer markets, bond markets didn't react <a href="https://www.benzinga.com/25/04/44762609/producer-inflation-sharply-drops-yet-treasury-yields-rise-heres-why-a-fed-rate-cut-in-may-could-be-back-on-the-table">with the usual optimism.</a>
Long-dated Treasury yields climbed steadily all week, with the 10-year yield breaking past 4.50%  — a level not seen since February. The 30-year yield briefly hit 5%, signaling that bond vigilantes —investors who dump bonds in protest of policy mistakes — have returned.
Amid widespread selling of U.S. Treasury bonds and the dollar, gold reaffirmed its role as a haven, surging to a new all-time high above $3,200 per ounce.
On Wednesday, stocks skyrocketed after the Trump administration announced a 90-day suspension of tariffs for most trade partners — China being the notable exception, with levies surging to 145%. The move triggered the biggest one-day rally on <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44720903/nasdaq-100-eyes-strongest-day-since-2008-as-magnificent-seven-add-15-trillion-in-historic-market-rally">Wall Street since 2008.</a>
Still, that positive momentum faded quickly. By the week's end, investor sentiment was once again clouded by uncertainty. The White House remains committed to its hardline tariff policy against China, even as Beijing retaliated with counter-tariffs on U.S. goods that now <a href="https://www.benzinga.com/markets/25/04/44756353/xi-jinping-says-there-are-no-winners-in-tariff-war-as-china-slaps-125-tariffs-on-us-goods-urges-trump-to-immediately-correct-wrongdoings">reach as high as 125%.</a>
Meanwhile, first-quarter earnings reports from banking giants including JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) and Wells Fargo Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) delivered encouraging numbers. Yet, investors remain cautious as the true impact of tariffs likely won't be visible until the second-quarter results.
<a href="https://www.benzinga.com/25/04/44760533/jpmorgan-kicks-off-earnings-season-strong-investment-banking-wealth-management-lead-revenue-surge">&#8220;The economy is facing considerable turbulence,"</a> JPMorgan CEO Jamie Dimon said.
More troubling are signs from Main Street. American consumers are growing increasingly pessimistic.
The <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44764554/consumer-sentiment-crashes-to-3-year-lows-as-inflation-expectations-spike-to-1981-highs">University of Michigan's preliminary consumer sentiment</a> index for April plunged to its lowest level since mid-2022. Expectations for inflation jumped sharply: one-year outlooks soared to 6.7%, the highest since 1981, while five-year expectations climbed to 4.4%, the highest since 1990.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44770031/will-a-fed-pivot-rekindle-the-bitcoin-bull-run-if-yes-expect-a-shift-in-institutional-sentiment-experts-say">Will A Fed Pivot Rekindle The Bitcoin Bull Run? If Yes, Expect A &#8216;Shift In Institutional Sentiment,&#8217; Experts Say</a></li>
</ul>
Image: Shutterstock

Equities

Government

Large Cap

Macro Economic Events

Regulations

Bonds

Treasuries

Econ #s

Economics

Wall Street Panic Extends To Main Street As US-China Trade War Escalates, Bond Vigilantes Make A Comeback: This Week In Markets

News

General

PRZO

ParaZero Technologies Receives Nasdaq Minimum Bid Price Notification

TTNP

Titan Pharmaceuticals Reveals $1M Private Placement Of Convertible Preferred Stock

Mortgage rates spiked to their highest level in nearly two months, with the average 30-year fixed climbing to 7.1% on Friday, according to Mortgage News Daily. The sharp increase — 13 basis points in a single day — wrapped up one of the most turbulent weeks for <a href="https://www.benzinga.com/markets/bonds">bonds</a> in decades.
What To Know: The surge followed a string of economic surprises, including newly introduced trade tariffs and conflicting signals from recent inflation data.
Midweek, rates began rising after former President Donald Trump imposed <a href="https://www.benzinga.com/25/04/44756759/new-research-shows-donald-trumps-25-tariffs-could-cost-auto-companies-108billion-report">widespread tariffs</a>. Though many were later scaled back, levies on Chinese goods <a href="https://www.benzinga.com/news/global/25/04/44762211/10-companies-with-exposure-to-trumps-china-tariff-war-ford-tesla-apple-disney-and-more">remained steep at 145%</a>.
Even as inflation came in softer than anticipated, bond yields continued to rise, sending mortgage rates even higher. Matthew Graham, COO of Mortgage News Daily, <a href="https://www.cnbc.com/2025/04/11/mortgage-rates-surge-tariffs-bond-market.html">told</a> CNBC that this past week could be viewed as either an outlier or a continuation of a long-running trend in rate volatility.
"Unless your career began before 1981, you just lived through the worst week you've ever seen in terms of the jump in 10-year yields," he said.
Read Also: <a href="https://www.benzinga.com/trading-ideas/25/04/44772209/3-big-brand-stocks-to-lean-on-during-tariff-troubles">3 Big Brand Stocks To Lean On During Tariff Troubles</a>
The timing is tough for the housing market, which typically sees heightened activity in the spring. Affordability, already strained, could worsen with borrowing costs on the rise.
"Forget about housing in this environment," said Nancy Lazar, chief global economist at Piper Sandler, in an interview with CNBC. She cited both higher mortgage rates and growing consumer anxiety around the job market as key challenges.
The University of Michigan&#8217;s latest consumer sentiment report added to the unease Friday, showing inflation expectations climbing to 6.7% — <a href="https://www.benzinga.com/government/regulations/25/04/44769110/wall-street-rebounds-jpmorgan-jumps-on-strong-q1-earnings-whats-driving-markets-friday">the highest since 1981</a>.
Meanwhile, <a href="https://www.benzinga.com/government/regulations/25/04/44769110/wall-street-rebounds-jpmorgan-jumps-on-strong-q1-earnings-whats-driving-markets-friday">broader financial markets rebounded</a> sharply Friday afternoon. Investors welcomed <a href="https://www.benzinga.com/25/04/44760533/jpmorgan-kicks-off-earnings-season-strong-investment-banking-wealth-management-lead-revenue-surge">strong bank earnings</a> and milder inflation data, helping lift major indexes despite ongoing tariff tensions. Treasury yields retreated slightly, with the 30-year falling to 4.90%.
Read Also: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44770031/will-a-fed-pivot-rekindle-the-bitcoin-bull-run-if-yes-expect-a-shift-in-institutional-sentiment-experts-say">Will A Fed Pivot Rekindle The Bitcoin Bull Run? If Yes, Expect A &#8216;Shift In Institutional Sentiment,&#8217; Experts Say</a></li>
</ul>
Photo: Shutterstock

Real Estate

Mortgage Rates Hit 7.1% As Bond Market Volatility, Trade Tariffs Shake Markets

Aon plc Class A Ordinary Shares Increases Quarterly Dividend From $ $0.675 To $$0.745 Per Share

JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) CEO Jamie Dimon offered more insights on President Donald Trump's tariff policies and the possible effects on businesses and the economy during the company's first-quarter earnings <a href="https://www.benzinga.com/government/regulations/25/04/44769110/wall-street-rebounds-jpmorgan-jumps-on-strong-q1-earnings-whats-driving-markets-friday">call on Friday morning. </a>
What To Know: Prior to the earnings call, the CEO of the country's largest bank said he spoke with JPMorgan economist Michael Farley, who updated the bank&#8217;s most current forecast, which calls for 50/50 chances of a recession due to the ongoing global trade tensions. 
Read Next:<a href="https://www.benzinga.com/news/global/25/04/44762211/10-companies-with-exposure-to-trumps-china-tariff-war-ford-tesla-apple-disney-and-more"> 10 Companies With Exposure To Trump&#8217;s China Tariff War: Ford, Tesla, Apple, Disney And More&nbsp;</a>
Dimon added that he hopes to see the Trump administration begin making trade deals and noted comments from the White House that they are in discussions with between 70 and 80 people. 
 "I think that would be good for everybody and they want to do it too," he said. 
Dimon pointed out that the analyst community has lowered the consensus S&amp;P 500 growth forecast from 10% to only 5% growth in 2025. He then predicted the forecast to be lowered even further in the near term. "My guess is that it [will] be zero and negative five probably the next month.&#8221;
He added that, anecdotally, businesses are in "wait and see" mode and are postponing hiring, expansions and M&amp;A deals while the future remains uncertain. 
"People have to adjust to this new environment," Dimon said.&nbsp;
In prepared<a href="https://www.benzinga.com/pressreleases/25/04/b44757876/jpmorganchase-reports-first-quarter-2025-financial-results"> remarks</a>, Dimon added that "the economy is facing considerable turbulence" and that "our fortress balance sheet enables the Firm to be a pillar of strength, particularly during volatile or challenging times." 
JPM Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, JPMorgan Chase shares were up 4.8% at $238.01 at the time of publication Friday.&nbsp;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44695907/elon-musk-calls-trump-trade-advisor-peter-navarro-dumber-than-sack-of-bricks-defends-tesla-as-the-most-american-made-cars">Elon Musk Calls Trump Trade Advisor Peter Navarro &#8216;Dumber Than Sack Of Bricks,&#8217; Defends Tesla As &#8216;Most American-Made Cars&#8217;&nbsp;</a></li>
</ul>
Image: Shutterstock

Earnings

Guidance

Management

Markets

Movers

JPMorgan CEO Jamie Dimon Expects S&P 500 Growth Forecast To Be Cut

The Beachbody Company, Inc. Class A Common Stock

BODI

The Beachbody Company Receives Notice From The NYSE Regarding Listing Compliance

Needham analyst Tom Nikic <a target="_blank" href="https://www.benzinga.com/quote/NKE/analyst-ratings" rel="noreferrer noopener">reiterated a Buy rating </a>on the shares of Nike Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) with a price forecast of $75.00.
According to the analyst, monitoring collectible sneaker trends is a way to gauge broader sneaker demand. High-demand releases, those selling out quickly at launch and fetching premiums on resale sites like StockX and GOAT often indicate a strong market.
Tariffs are expected to<a target="_blank" href="https://www.benzinga.com/news/global/25/04/44741043/nike-stock-tumbles-as-us-china-trade-war-intensifies-what-you-need-to-know" rel="noreferrer noopener"> heavily influence the footwear sector</a> in the short term, said the analyst. With nearly all U.S. footwear being imported, current tariffs 145% on Chinese goods and 10% elsewhere pose a significant threat to profit margins.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44752669/walmarts-resilience-shines-with-broad-ebit-forecast-and-strong-growth-engines-analyst-says" rel="noreferrer noopener">Walmart's Resilience Shines With Broad EBIT Forecast And Strong Growth Engines, Analyst Says</a>
As a result, stock movements are likely to be driven more by evolving tariff news than business fundamentals, creating uncertainty for investors, noted the analyst.
Nike has launched the ReactX Rejuven8, a molded rubber slip-on that resembles Crocs. The shoe, featuring perforations on the upper, sold out quickly in limited quantities and is gaining traction on social media.
While it's early, the analyst suggests that if the buzz continues, the model could pose competitive pressure for Crocs Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CROX#NASDAQ">CROX</a>).
Nike received strong consumer response to its Pegasus Premium running shoe, with successful launches in both January and March.
This momentum could indicate early signs of a rebound in Nike's running category.
While it's too soon to say Nike is impacting rivals like Hoka and On Holding AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>), the analyst suggests it's a space worth watching.
Brand-level analysis suggests that Nike could see a year-over-year uptick in high-heat sneaker releases, partly due to last April's underwhelming Jordan lineup.
Price Action: NKE shares traded lower by 0.33% at $54.18 at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44752453/bofa-turns-bullish-on-levi-strauss-with-strong-sales-and-low-china-exposure" target="_blank" rel="noreferrer noopener">Beyoncé Partnership, Strong Sales And Low China Exposure &#8211; Analyst Upgrades Levi Strauss To Buy</a></li>
</ul>
Photo via Shutterstock

Analyst Color

Price Target

Reiteration

Analyst Ratings

Trading Ideas

CROX

ONON

Nike's Sneaker Buzz And Tariff Risks Could Shape Its Future: Analyst

HINGHAM, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- HINGHAM INSTITUTION FOR SAVINGS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIFS#NASDAQ">HIFS</a>), Hingham, Massachusetts announced results for the quarter ended March 31, 2025.
Earnings
Net income for the quarter ended March 31, 2025 was $7,124,000 or $3.27 per share basic and $3.24 per share diluted, as compared to $6,868,000 or $3.17 per share basic and $3.13 per share diluted for the same period last year. The Bank's annualized return on average equity for the first quarter of 2025 was 6.46%, and the annualized return on average assets was 0.64%, as compared to 6.63% and 0.63% for the same period last year. Net income per share (diluted) for the first quarter of 2025 increased by 3.5% compared to the same period in 2024.
Core net income for the quarter ended March 31, 2025, which represents net income excluding the after-tax net gain on equity securities, both realized and unrealized, was $6,125,000 or $2.81 per share basic and $2.78 per share diluted, as compared to $2,213,000 or $1.02 per share basic and $1.01 per share diluted for the same period last year. The Bank's annualized core return on average equity for the first quarter of 2025 was 5.56% and the annualized core return on average assets was 0.55%, as compared to 2.14% and 0.20% for the same period last year. Core net income per share (diluted) for the first quarter of 2025 increased by 175.2% compared to the same period in 2024.

HIFS

Hingham Institution For Savings Q1 Core EPS Rises To $2.78 From $1.01 Last Year

Barclays analyst Benjamin Budish maintains KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) with a Overweight and lowers the price target from $181 to $129.

Barclays Maintains Overweight on KKR, Lowers Price Target to $129

CENTENNIAL, CO / <a href="https://www.accessnewswire.com/">ACCESS Newswire</a> / April 11, 2025 / NioCorp Developments Ltd. ("NioCorp" or the "Company") (NASDAQ:<a href="https://www.benzinga.com/stock/NB#NASDAQ">NB</a>) today provided its preliminary financial results for the three- and nine-month periods ended March 31, 2025.
Selected financial results expectations for the periods include:
Loss for the three-month period ended March 31, 2025, of $5.4 million, or $0.11 per share, compared to a loss for the three-month period ended March 31, 2024, of $4.2 million, or $0.11 per share.
Loss for the nine-month period ended March 31, 2025, of $8.0 million, or $0.17 per share, compared to a loss for the nine-month period ended March 31, 2024, of $11.0 million, or $0.29 per share.
NioCorp intends to file its unaudited interim condensed consolidated financial statements for the period ended March 31, 2025, in its Quarterly Report on Form 10-Q on or before May 15, 2025.

NioCorp Announces Preliminary Financial Results For Three Month Period Ended March 31, 2025. Loss Of $5.4M Or $0.11 Per Share Vs Loss of $4.2M Or $0.11 Per Share in March, 2024

Barclays analyst Andrew Mok maintains Humana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) with a Equal-Weight and raises the price target from $270 to $322.

Barclays Maintains Equal-Weight on Humana, Raises Price Target to $322

<a href="https://t.co/3rV9Eoehdf" title="https://t.co/3rV9Eoehdf">https://t.co/3rV9Eoehdf</a> <a href="https://t.co/mRoun7JMp0" title="https://t.co/mRoun7JMp0">https://t.co/mRoun7JMp0</a>

WORK Medical Technology Group Receives Written Notification From The Nasdaq Regarding Minimum Bid Price Deficiency

Barclays analyst Christine Cho maintains First Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) with a Overweight and lowers the price target from $236 to $204.

FSLR

Barclays Maintains Overweight on First Solar, Lowers Price Target to $204

Ratings for Western Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) were provided by 24 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">6</td>
<td align="right">12</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">5</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $77.58, a high estimate of $95.00, and a low estimate of $40.00. This current average has decreased by 9.44% from the previous average price target of $85.67. 
<img src="https://www.benzinga.com/files/images/story/2025/1744401687_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Western Digital among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Medhi Hosseini &#x7C;Susquehanna &#x7C;Lowers &#x7C;Neutral &#x7C; $40.00&#x7C;$72.00 &#x7C; 
&#x7C;Mark Miller &#x7C;Benchmark &#x7C;Announces &#x7C;Buy &#x7C; $55.00&#x7C;- &#x7C; 
&#x7C;Vijay Rakesh &#x7C;Mizuho &#x7C;Lowers &#x7C;Outperform &#x7C; $68.00&#x7C;$82.00 &#x7C; 
&#x7C;Timothy Arcuri &#x7C;UBS &#x7C;Lowers &#x7C;Neutral &#x7C; $50.00&#x7C;$74.00 &#x7C; 
&#x7C;Matthew Prisco &#x7C;Cantor Fitzgerald &#x7C;Lowers &#x7C;Overweight &#x7C; $65.00&#x7C;$95.00 &#x7C; 
&#x7C;Aaron Rakers &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $75.00&#x7C;$85.00 &#x7C; 
&#x7C;Asiya Merchant &#x7C;Citigroup &#x7C;Raises &#x7C;Buy &#x7C; $64.00&#x7C;$60.45 &#x7C; 
&#x7C;Matthew Prisco &#x7C;Cantor Fitzgerald &#x7C;Maintains &#x7C;Overweight &#x7C; $95.00&#x7C;$95.00 &#x7C; 
&#x7C;Matthew Prisco &#x7C;Cantor Fitzgerald &#x7C;Maintains &#x7C;Overweight &#x7C; $95.00&#x7C;$95.00 &#x7C; 
&#x7C;Timothy Arcuri &#x7C;UBS &#x7C;Raises &#x7C;Neutral &#x7C; $74.00&#x7C;$70.00 &#x7C; 
&#x7C;Matt Bryson &#x7C;Wedbush &#x7C;Maintains &#x7C;Outperform &#x7C; $95.00&#x7C;$95.00 &#x7C; 
&#x7C;Matthew Prisco &#x7C;Cantor Fitzgerald &#x7C;Maintains &#x7C;Overweight &#x7C; $95.00&#x7C;$95.00 &#x7C; 
&#x7C;Toshiya Hari &#x7C;Goldman Sachs &#x7C;Raises &#x7C;Neutral &#x7C; $80.00&#x7C;$70.00 &#x7C; 
&#x7C;Timothy Arcuri &#x7C;UBS &#x7C;Lowers &#x7C;Neutral &#x7C; $70.00&#x7C;$78.00 &#x7C; 
&#x7C;Asiya Merchant &#x7C;Citigroup &#x7C;Lowers &#x7C;Buy &#x7C; $80.00&#x7C;$82.00 &#x7C; 
&#x7C;Tristan Gerra &#x7C;Baird &#x7C;Lowers &#x7C;Outperform &#x7C; $80.00&#x7C;$100.00 &#x7C; 
&#x7C;Matthew Prisco &#x7C;Cantor Fitzgerald &#x7C;Maintains &#x7C;Overweight &#x7C; $95.00&#x7C;$95.00 &#x7C; 
&#x7C;Medhi Hosseini &#x7C;Susquehanna &#x7C;Lowers &#x7C;Neutral &#x7C; $72.00&#x7C;$83.00 &#x7C; 
&#x7C;Kevin Cassidy &#x7C;Rosenblatt &#x7C;Lowers &#x7C;Buy &#x7C; $90.00&#x7C;$95.00 &#x7C; 
&#x7C;Wamsi Mohan &#x7C;B of A Securities &#x7C;Raises &#x7C;Buy &#x7C; $84.00&#x7C;$80.00 &#x7C; 
&#x7C;C J Muse &#x7C;Cantor Fitzgerald &#x7C;Maintains &#x7C;Overweight &#x7C; $95.00&#x7C;$95.00 &#x7C; 
&#x7C;Tom O'Malley &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $80.00&#x7C;$90.00 &#x7C; 
&#x7C;Wamsi Mohan &#x7C;B of A Securities &#x7C;Lowers &#x7C;Buy &#x7C; $80.00&#x7C;$89.00 &#x7C; 
&#x7C;Aaron Rakers &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $85.00&#x7C;$95.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Western Digital. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Western Digital compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Western Digital's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Western Digital's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/WDC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Western Digital analyst ratings.</a>
<h2>Discovering Western Digital: A Closer Look</h2>
Western Digital is a leading, vertically integrated supplier of hard disk drives. The HDD market is a practical duopoly with, Western Digital and Seagate being the two largest players. Western Digital designs and manufacturers its HDDs, with much of the manufacturing and workforce located in Asia. The primary consumers of HDDs are data centers.
<h3>Western Digital: Delving into Financials</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Western Digital's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 41.33% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Western Digital's net margin excels beyond industry benchmarks, reaching 13.56%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 4.89%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.31%, the company showcases effective utilization of assets.
Debt Management: Western Digital's debt-to-equity ratio is below the industry average at 0.61, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Western Digital: 24 Analysts Share Their Views

Investors with a lot of money to spend have taken a bearish stance on General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with GM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 15 uncommon options trades for General Motors.
This isn't normal.
The overall sentiment of these big-money traders is split between 20% bullish and 66%, bearish.
Out of all of the special options we uncovered, 9 are puts, for a total amount of $493,410, and 6 are calls, for a total amount of $732,731.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $35.0 to $60.0 for General Motors over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of General Motors stands at 3144.5, with a total volume reaching 9,479.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in General Motors, situated within the strike price corridor from $35.0 to $60.0, throughout the last 30 days.
<h3>General Motors 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744401671_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$5.3</td>
<td>$4.85</td>
<td>$4.85</td>
<td>$47.00</td>
<td>$307.7K</td>
<td>1.8K</td>
<td>636</td>
</tr>
<tr>
<td>GM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>04/25/25</td>
<td>$2.43</td>
<td>$2.25</td>
<td>$2.28</td>
<td>$43.00</td>
<td>$226.0K</td>
<td>30</td>
<td>1.1K</td>
</tr>
<tr>
<td>GM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$7.9</td>
<td>$7.85</td>
<td>$7.9</td>
<td>$47.00</td>
<td>$158.7K</td>
<td>4.0K</td>
<td>233</td>
</tr>
<tr>
<td>GM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$8.35</td>
<td>$8.25</td>
<td>$8.25</td>
<td>$40.00</td>
<td>$108.9K</td>
<td>3.9K</td>
<td>134</td>
</tr>
<tr>
<td>GM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$2.18</td>
<td>$2.11</td>
<td>$2.17</td>
<td>$45.00</td>
<td>$65.1K</td>
<td>3.1K</td>
<td>877</td>
</tr>
</tbody>
</table>

<h3>About General Motors</h3>
General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under three segments: GM North America, GM International, and GM Financial. The United States now has four brands instead of eight under old GM. The company regained its US market share leadership in 2022, after losing it to Toyota due to the chip shortage in 2021. 2024's share was 17.0%. The Cruise autonomous vehicle arm, which GM now owns outright, previously operated driverless geofenced AV robotaxi services in San Francisco and other cities, but after a 2023 accident, GM decided that it will focus on personal AVs. GM Financial became the company's captive finance arm in 2010 via the purchase of AmeriCredit.
After a thorough review of the options trading surrounding General Motors, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>General Motors's Current Market Status</h3>
<ul>
<li>With a volume of 7,154,626, the price of GM is down -0.1% at $43.69. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 18 days.</li>
</ul>
<h3>Expert Opinions on General Motors</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $50.4.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Bernstein downgraded its rating to Underperform, setting a price target of $35. 
&#x2A; An analyst from UBS downgraded its action to Neutral with a price target of $51. 
&#x2A; An analyst from Goldman Sachs persists with their Buy rating on General Motors, maintaining a target price of $63. 
&#x2A; An analyst from Mizuho persists with their Outperform rating on General Motors, maintaining a target price of $55. 
&#x2A; An analyst from Piper Sandler persists with their Neutral rating on General Motors, maintaining a target price of $48. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for General Motors with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

General Motors Options Trading: A Deep Dive into Market Sentiment

Analysts' ratings for Compass (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COMP#NYSE">COMP</a>) over the last quarter vary from bullish to bearish, as provided by 12 analysts.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">9</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Compass, presenting an average target of $10.71, a high estimate of $13.00, and a low estimate of $8.50. Witnessing a positive shift, the current average has risen by 12.74% from the previous average price target of $9.50.
<img src="https://www.benzinga.com/files/images/story/2025/1744401666_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Compass. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Lloyd Walmsley &#x7C;UBS &#x7C;Lowers &#x7C;Buy &#x7C; $11.00&#x7C;$12.00 &#x7C; 
&#x7C;Michael Ng &#x7C;Goldman Sachs &#x7C;Raises &#x7C;Buy &#x7C; $11.00&#x7C;$10.00 &#x7C; 
&#x7C;Michael Ng &#x7C;Goldman Sachs &#x7C;Raises &#x7C;Buy &#x7C; $10.00&#x7C;$9.00 &#x7C; 
&#x7C;Bernie McTernan &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $12.00&#x7C;$12.00 &#x7C; 
&#x7C;Matthew Bouley &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $9.00&#x7C;$7.00 &#x7C; 
&#x7C;Brian Nowak &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Equal-Weight &#x7C; $8.50&#x7C;$6.00 &#x7C; 
&#x7C;Jason Helfstein &#x7C;Oppenheimer &#x7C;Raises &#x7C;Outperform &#x7C; $13.00&#x7C;$12.00 &#x7C; 
&#x7C;Michael Ng &#x7C;Goldman Sachs &#x7C;Raises &#x7C;Buy &#x7C; $9.00&#x7C;$8.00 &#x7C; 
&#x7C;Lloyd Walmsley &#x7C;UBS &#x7C;Raises &#x7C;Buy &#x7C; $12.00&#x7C;$11.00 &#x7C; 
&#x7C;Bernie McTernan &#x7C;Needham &#x7C;Raises &#x7C;Buy &#x7C; $12.00&#x7C;$10.00 &#x7C; 
&#x7C;Lloyd Walmsley &#x7C;UBS &#x7C;Raises &#x7C;Buy &#x7C; $11.00&#x7C;$7.00 &#x7C; 
&#x7C;Bernie McTernan &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $10.00&#x7C;$10.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Compass. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Compass compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Compass's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Compass's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/COMP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Compass analyst ratings.</a>
<h2>All You Need to Know About Compass</h2>
Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.
<h3>Compass's Financial Performance</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Compass's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 25.9%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: Compass's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -2.93%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Compass's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -9.67%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -3.41%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 1.22, Compass adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

COMP

Compass Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)

Financial giants have made a conspicuous bearish move on AbbVie. Our analysis of options history for AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) revealed 20 unusual trades.
Delving into the details, we found 45% of traders were bullish, while 55% showed bearish tendencies. Out of all the trades we spotted, 11 were puts, with a value of $503,310, and 9 were calls, valued at $449,277.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $130.0 to $220.0 for AbbVie during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in AbbVie's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to AbbVie's substantial trades, within a strike price spectrum from $130.0 to $220.0 over the preceding 30 days.
<h3>AbbVie Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744401665_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/02/25</td>
<td>$6.15</td>
<td>$5.8</td>
<td>$6.1</td>
<td>$175.00</td>
<td>$118.9K</td>
<td>13</td>
<td align="right">263</td>
</tr>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$11.7</td>
<td>$11.65</td>
<td>$11.65</td>
<td>$175.00</td>
<td>$102.5K</td>
<td>2.0K</td>
<td align="right">135</td>
</tr>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$12.9</td>
<td>$12.75</td>
<td>$13.06</td>
<td>$165.00</td>
<td>$72.8K</td>
<td>279</td>
<td align="right">84</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$10.85</td>
<td>$10.8</td>
<td>$10.72</td>
<td>$180.00</td>
<td>$54.0K</td>
<td>2.3K</td>
<td align="right">78</td>
</tr>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$11.3</td>
<td>$11.25</td>
<td>$11.3</td>
<td>$155.00</td>
<td>$51.9K</td>
<td>611</td>
<td align="right">62</td>
</tr>
</tbody>
</table>

<h3>About AbbVie</h3>
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
<h3>Present Market Standing of AbbVie</h3>
<ul>
<li>With a trading volume of 6,292,250, the price of ABBV is up by 0.78%, reaching $175.56.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 14 days from now.</li>
</ul>
<h3>What The Experts Say On AbbVie</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $217.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Morgan Stanley continues to hold a Overweight rating for AbbVie, targeting a price of $241. 
&#x2A; An analyst from Goldman Sachs has revised its rating downward to Neutral, adjusting the price target to $194. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for AbbVie, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

ABBV

AbbVie Unusual Options Activity

Investors with a lot of money to spend have taken a bullish stance on PepsiCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PEP, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 8 uncommon options trades for PepsiCo.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 50%, bearish.
Out of all of the special options we uncovered, 6 are puts, for a total amount of $831,170, and 2 are calls, for a total amount of $93,747.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $135.0 to $160.0 for PepsiCo over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of PepsiCo stands at 2236.0, with a total volume reaching 923.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in PepsiCo, situated within the strike price corridor from $135.0 to $160.0, throughout the last 30 days.
<h3>PepsiCo 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744401660_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PEP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$15.5</td>
<td>$15.1</td>
<td>$15.22</td>
<td>$160.00</td>
<td>$502.2K</td>
<td>1.9K</td>
<td align="right">331</td>
</tr>
<tr>
<td>PEP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$6.45</td>
<td>$6.3</td>
<td>$6.45</td>
<td>$140.00</td>
<td>$116.1K</td>
<td>1.6K</td>
<td align="right">18</td>
</tr>
<tr>
<td>PEP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$2.99</td>
<td>$2.74</td>
<td>$2.92</td>
<td>$135.00</td>
<td>$96.3K</td>
<td>5.5K</td>
<td align="right">88</td>
</tr>
<tr>
<td>PEP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$7.4</td>
<td>$7.35</td>
<td>$7.4</td>
<td>$145.00</td>
<td>$58.4K</td>
<td>953</td>
<td align="right">259</td>
</tr>
<tr>
<td>PEP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$8.5</td>
<td>$8.4</td>
<td>$8.5</td>
<td>$135.00</td>
<td>$53.5K</td>
<td>920</td>
<td align="right">64</td>
</tr>
</tbody>
</table>

<h3>About PepsiCo</h3>
PepsiCo is a global leader in snacks and beverages, owning well-known household brands including Pepsi, Mountain Dew, Gatorade, Lay's, Cheetos, and Doritos, among others. The company dominates the global savory snacks market and also ranks as the second-largest beverage provider in the world (behind Coca-Cola) with diversified exposure to carbonated soft drinks, or CSD, as well as water, sports, and energy drink offerings. Convenience foods account for approximately 55% of its total revenue, with beverages making up the rest. Pepsi owns the bulk of its manufacturing and distribution capacity in the US and overseas. International markets made up 40% of both total sales and operating profits in 2024.
Following our analysis of the options activities associated with PepsiCo, we pivot to a closer look at the company's own performance.
<h3>PepsiCo's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 5,302,723, the PEP's price is up by 0.46%, now at $144.8. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 13 days.</li>
</ul>
<h3>Professional Analyst Ratings for PepsiCo</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $156.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Barclays downgraded its rating to Equal-Weight, setting a price target of $156. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for PepsiCo with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

A Closer Look at PepsiCo's Options Market Dynamics

14 analysts have expressed a variety of opinions on Mid-America Apartment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAA#NYSE">MAA</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Mid-America Apartment, presenting an average target of $166.29, a high estimate of $190.00, and a low estimate of $152.00. This current average reflects an increase of 2.77% from the previous average price target of $161.81. 
<img src="https://www.benzinga.com/files/images/story/2025/1744401657_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Mid-America Apartment among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;-----------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Richard Hightower &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $160.00&#x7C;$163.00 &#x7C; 
&#x7C;Buck Horne &#x7C;Raymond James &#x7C;Raises &#x7C;Strong Buy &#x7C; $185.00&#x7C;$180.00 &#x7C; 
&#x7C;Michael Lewis &#x7C;Truist Securities &#x7C;Raises &#x7C;Buy &#x7C; $174.00&#x7C;$158.00 &#x7C; 
&#x7C;Linda Tsai &#x7C;Jefferies &#x7C;Raises &#x7C;Buy &#x7C; $190.00&#x7C;$148.00 &#x7C; 
&#x7C;Richard Hightower &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $163.00&#x7C;$152.00 &#x7C; 
&#x7C;Nicholas Yulico &#x7C;Scotiabank &#x7C;Raises &#x7C;Sector Outperform&#x7C; $182.00&#x7C;$173.00 &#x7C; 
&#x7C;Aaron Hecht &#x7C;JMP Securities &#x7C;Maintains &#x7C;Market Outperform&#x7C; $160.00&#x7C;$160.00 &#x7C; 
&#x7C;Steve Sakwa &#x7C;Evercore ISI Group &#x7C;Raises &#x7C;In-Line &#x7C; $159.00&#x7C;$155.00 &#x7C; 
&#x7C;Brad Heffern &#x7C;RBC Capital &#x7C;Raises &#x7C;Sector Perform &#x7C; $161.00&#x7C;$158.00 &#x7C; 
&#x7C;James Feldman &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $164.00&#x7C;$174.00 &#x7C; 
&#x7C;Richard Hightower &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $152.00&#x7C;$166.00 &#x7C; 
&#x7C;Adam Kramer &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Overweight &#x7C; $168.00&#x7C;$159.50 &#x7C; 
&#x7C;Steve Sakwa &#x7C;Evercore ISI Group &#x7C;Announces &#x7C;In-Line &#x7C; $155.00&#x7C;- &#x7C; 
&#x7C;John Kim &#x7C;BMO Capital &#x7C;Lowers &#x7C;Market Perform &#x7C; $155.00&#x7C;$157.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Mid-America Apartment. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Mid-America Apartment compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Mid-America Apartment's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Mid-America Apartment's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/MAA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Mid-America Apartment analyst ratings.</a>
<h2>Get to Know Mid-America Apartment Better</h2>
Mid-America Apartment Communities Inc or MAA, is a real estate investment trust engaged in the acquisition, operation, and development of multifamily apartment communities located in the southeastern and southwestern United States. The company operates two reportable segments; Same Store includes communities that the Company has owned and have been stabilized for at least a full 12 months as of the first day of the calendar year and Non-Same Store and Other includes recently acquired communities, communities being developed or in lease-up, communities that have been disposed of or identified for disposition, communities that have experienced a casualty loss and stabilized communities that do not meet the requirements to be Same Store communities.
<h3>Unraveling the Financial Story of Mid-America Apartment</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Mid-America Apartment's remarkable performance in 3M is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 1.4%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 30.16%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Mid-America Apartment's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.78%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Mid-America Apartment's ROA stands out, surpassing industry averages. With an impressive ROA of 1.41%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Mid-America Apartment's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.84.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Mid-America Apartment Stock

Financing

Press Releases

Two Senior MEDIROM Mother Labs Executives Invest in Mother Labs' Series A Financing at a Pre-Money Valuation of JPY9 Billion (as of December 1, 2024, approximately USD $59,000,000)

MEDIROM Healthcare Technologies Inc. Announces Closing of Public Offering

MEDIROM Healthcare Technology's Subsidiary, MEDIROM MOTHER Labs, Raises an Aggregate Total of JPY260.3 Million in its Series A Financing Round

MEDIROM Healthcare Technologies Inc. Announces November 2024 Key Performance Indicators (KPIs)

Contracts

MEDIROM MOTHER Labs Provides MOTHER Bracelet®︎ Device and Remote Health Monitoring System, REMONY, to TOPPAN Inc.

Completion of Offering and Increase in Registered Capital

MEDIROM Healthcare Technologies Inc. Announces December 2024 Key Performance Indicators (KPIs)

MEDIROM Healthcare Technologies Inc. Announces Preliminary, Unaudited Financial Results for Full Year 2024 Under Japanese GAAP

Health Care

MEDIROM Mother Labs Executive Makes Additional Investment in Mother Labs' Series A Financing at a Pre-Money Valuation of JPY9 Billion (as of March 13, 2025, Approximately US$60 Million)

Comments

MEDIROM Healthcare Techs

MEDIROM Healthcare Techs (MRM) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル